Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Strong Relation between Muscle Mass Determined by D3-creatine Dilution, Physical Performance and Incidence of Falls and Mobility Limitations in a Prospective Cohort of Older Men.

Cawthon PM, Orwoll ES, Peters KE, Ensrud KE, Cauley JA, Kado DM, Stefanick ML, Shikany JM, Strotmeyer ES, Glynn NW, Caserotti P, Shankaran M, Hellerstein M, Cummings SR, Evans WJ; Osteoporotic Fractures in Men (MrOS) Study Research Group.

J Gerontol A Biol Sci Med Sci. 2018 Jun 12. doi: 10.1093/gerona/gly129. [Epub ahead of print]

PMID:
29897420
2.

Dilution of oral D3 -Creatine to measure creatine pool size and estimate skeletal muscle mass: development of a correction algorithm.

Shankaran M, Czerwieniec G, Fessler C, Wong PA, Killion S, Turner SM, Hellerstein MK, Evans WJ.

J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):540-546. doi: 10.1002/jcsm.12278. Epub 2018 Apr 16.

3.

Effect of resistance training and protein intake pattern on myofibrillar protein synthesis and proteome kinetics in older men in energy restriction.

Murphy CH, Shankaran M, Churchward-Venne TA, Mitchell CJ, Kolar NM, Burke LM, Hawley JA, Kassis A, Karagounis LG, Li K, King C, Hellerstein M, Phillips SM.

J Physiol. 2018 Jun;596(11):2091-2120. doi: 10.1113/JP275246. Epub 2018 Apr 17.

PMID:
29532476
4.

Early and brain region-specific decrease of de novo cholesterol biosynthesis in Huntington's disease: A cross-validation study in Q175 knock-in mice.

Shankaran M, Di Paolo E, Leoni V, Caccia C, Ferrari Bardile C, Mohammed H, Di Donato S, Kwak S, Marchionini D, Turner S, Cattaneo E, Valenza M.

Neurobiol Dis. 2017 Feb;98:66-76. doi: 10.1016/j.nbd.2016.11.013. Epub 2016 Nov 30.

PMID:
27913290
5.

Proteome-wide muscle protein fractional synthesis rates predict muscle mass gain in response to a selective androgen receptor modulator in rats.

Shankaran M, Shearer TW, Stimpson SA, Turner SM, King C, Wong PY, Shen Y, Turnbull PS, Kramer F, Clifton L, Russell A, Hellerstein MK, Evans WJ.

Am J Physiol Endocrinol Metab. 2016 Mar 15;310(6):E405-17. doi: 10.1152/ajpendo.00257.2015. Epub 2015 Dec 29.

6.

Circulating protein synthesis rates reveal skeletal muscle proteome dynamics.

Shankaran M, King CL, Angel TE, Holmes WE, Li KW, Colangelo M, Price JC, Turner SM, Bell C, Hamilton KL, Miller BF, Hellerstein MK.

J Clin Invest. 2016 Jan;126(1):288-302. doi: 10.1172/JCI79639. Epub 2015 Dec 14.

7.

Greater muscle protein synthesis and mitochondrial biogenesis in males compared with females during sprint interval training.

Scalzo RL, Peltonen GL, Binns SE, Shankaran M, Giordano GR, Hartley DA, Klochak AL, Lonac MC, Paris HL, Szallar SE, Wood LM, Peelor FF 3rd, Holmes WE, Hellerstein MK, Bell C, Hamilton KL, Miller BF.

FASEB J. 2014 Jun;28(6):2705-14. doi: 10.1096/fj.13-246595. Epub 2014 Mar 5.

PMID:
24599968
8.

The effect of long term calorie restriction on in vivo hepatic proteostatis: a novel combination of dynamic and quantitative proteomics.

Price JC, Khambatta CF, Li KW, Bruss MD, Shankaran M, Dalidd M, Floreani NA, Roberts LS, Turner SM, Holmes WE, Hellerstein MK.

Mol Cell Proteomics. 2012 Dec;11(12):1801-14. doi: 10.1074/mcp.M112.021204. Epub 2012 Sep 13.

9.

Differential in vivo effects on target pathways of a novel arylpyrazole glucocorticoid receptor modulator compared with prednisolone.

Roohk DJ, Varady KA, Turner SM, Emson CL, Gelling RW, Shankaran M, Lindwall G, Shipp LE, Scanlan TS, Wang JC, Hellerstein MK.

J Pharmacol Exp Ther. 2010 Apr;333(1):281-9. doi: 10.1124/jpet.109.162487. Epub 2010 Jan 11.

10.

Measurement of brain microglial proliferation rates in vivo in response to neuroinflammatory stimuli: application to drug discovery.

Shankaran M, Marino ME, Busch R, Keim C, King C, Lee J, Killion S, Awada M, Hellerstein MK.

J Neurosci Res. 2007 Aug 15;85(11):2374-84.

PMID:
17551981
11.

Discovery of novel hippocampal neurogenic agents by using an in vivo stable isotope labeling technique.

Shankaran M, King C, Lee J, Busch R, Wolff M, Hellerstein MK.

J Pharmacol Exp Ther. 2006 Dec;319(3):1172-81. Epub 2006 Sep 14.

12.

Paroxetine is effective in desensitizing 5-HT1A receptor function in adult offspring exposed prenatally to cocaine.

Chen Z, Tetzlaff J, Sripathirathan K, Carrasco GA, Shankaran M, Van De Kar LD, Muma NA, Battaglia G.

Psychopharmacology (Berl). 2005 Jul;180(2):316-26. Epub 2005 Apr 28.

PMID:
15864558
13.

Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.

Damjanoska KJ, Muma NA, Zhang Y, D'Souza DN, Garcia F, Carrasco GA, Kindel GH, Haskins KA, Shankaran M, Petersen BR, Van De Kar LD.

J Pharmacol Exp Ther. 2003 Mar;304(3):1209-16.

14.
16.

Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine.

Shankaran M, Yamamoto BK, Gudelsky GA.

Eur J Pharmacol. 1999 Dec 3;385(2-3):103-10.

PMID:
10607865
17.
19.

Effect of 3,4-methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin.

Shankaran M, Gudelsky GA.

Pharmacol Biochem Behav. 1998 Dec;61(4):361-6.

PMID:
9802829

Supplemental Content

Loading ...
Support Center